학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 932건 | 목록 30~40
Academic Journal
Wolchok JD; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Chiarion-Sileni V; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Rutkowski P; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Cowey CL; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Schadendorf D; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Wagstaff J; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Queirolo P; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Dummer R; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Butler MO; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Hill AG; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Postow MA; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Gaudy-Marqueste C; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Medina T; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Lao CD; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Walker J; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Márquez-Rodas I; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Haanen JBAG; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Guidoboni M; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Maio M; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Schöffski P; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Carlino MS; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Sandhu S; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Lebbé C; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Ascierto PA; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Long GV; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Ritchings C; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Nassar A; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Askelson M; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Benito MP; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Wang W; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Hodi FS; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).; Larkin J; From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) - both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) - all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases-West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen - all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Bristol Myers Squibb, Uxbridge (A.N.), and the Royal Marsden Hospital, London (J.L.) - all in the United Kingdom; the Department of Dermatology, University of Zurich, Zurich, Switzerland (R.D.); University Health Network Princess Margaret Cancer Centre, Toronto (M.O.B.), and Cross Cancer Institute, University of Alberta, Edmonton (J.W.) - both in Canada; Tasman Oncology Research, Southport, QLD (A.G.H.), Westmead Hospital, Westmead, NSW (M.S.C.), Blacktown Hospital, Blacktown, NSW (M.S.C.), the Melanoma Institute Australia, University of Sydney (M.S.C., G.V.L.), Royal North Shore Hospital (G.V.L.), and Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (S.S.) - all in Australia; Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, Marseille (C.G.-M.), and Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP) Dermato-oncology, Clinical Investigation Center, the Cancer Institute, AP-HP Nord Paris Cité, INSERM Unité 976, and St. Louis Hospital, Paris (C.L.) - all in France; the University of Colorado Cancer Center, Aurora (T.M.); Rogel Cancer Center, University of Michigan, Ann Arbor (C.D.L.); Hospital General Universitario Gregorio Marañon, Madrid (I.M-R.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); University Hospital Leuven and Leuven Cancer Institute, KU Leuven, Leuven, Belgium (P.S.); Bristol Myers Squibb, Princeton, NJ (C.R., M.A., M.P.B., W.W.); and Dana-Farber Cancer Institute, Boston (F.S.H.).
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Academic Journal
Norton V; Department of Food and Nutritional Sciences, Harry Nursten, University of Reading, Reading, United Kingdom.; Wagstaff C; Department of Food and Nutritional Sciences, Harry Nursten, University of Reading, Reading, United Kingdom.; Rodriguez Garcia J; Department of Food and Nutritional Sciences, Harry Nursten, University of Reading, Reading, United Kingdom.; Nutrition and Food Science Area, Preventive Medicine and Public Health, Food Science, Toxicology and Forensic Medicine Department, Faculty of Pharmacy, Universitat de València, Avda. Vicent Andrés Estellés, s/n, 46100 Burjassot, València, Spain.; Lovegrove A; Sustainable Soils and Crops, Rothamsted Research, Harpenden, Hertfordshire, AL5 2JQ, United Kingdom.; Shewry P; Sustainable Soils and Crops, Rothamsted Research, Harpenden, Hertfordshire, AL5 2JQ, United Kingdom.; Charlton M; Allied Technical Centre, 1 Vanwall Place, Vanwall Business Park, Maidenhead, Berkshire, SL6 4UF, United Kingdom.; Gillett N; Allied Technical Centre, 1 Vanwall Place, Vanwall Business Park, Maidenhead, Berkshire, SL6 4UF, United Kingdom.; Tindall MJ; Department of Mathematics and Statistics, University of Reading, Reading, United Kingdom.; Institute of Cardiovascular and Metabolic Research, University of Reading, Whiteknights, Reading, RG6 6AA, United Kingdom.; Lignou S; Department of Food and Nutritional Sciences, Harry Nursten, University of Reading, Reading, United Kingdom.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101717957 Publication Model: eCollection Cited Medium: Internet ISSN: 2475-2991 (Electronic) Linking ISSN: 24752991 NLM ISO Abbreviation: Curr Dev Nutr Subsets: PubMed not MEDLINE
Academic Journal
Sgro, A.Blanco-Colino, R.Ahmed, W. U. R.Brindl, N.Gujjuri, R. R.Lapolla, P.Mills, E. C.Perez-Ajates, S.Soares, A. S.Varghese, C.Xu, W.McLean, K. A.Chapman, S. J.Espin-Basany, E.Glasbey, J. C.Mihaljevic, A.Nepogodiev, D.Pata, F.Pellino, G.Pockney, P.Dudi-Venkata, N. N.Egoroff, N.Ludbrook, IRaubenheimer, K.Richards, T.Delibegovic, S.Salibasic, M.Amjad, T.Dorr-Harim, C.Gedeon, N.Gsenger, J.Tachezy, M.Bini, S.Gallo, G.Gori, A.Picciariello, A.Podda, M.Riboni, C.Machatschek, M. J.Nguyen, A.Jakubauskas, M.Kryzauskas, M.Poskus, T.Kuiper, S. Z.Wang, J.Wells, C., IBissett, I. P.Augestad, K. M.Steinholt, IVieira, B. N.Juloski, J.Bautista, Anabitarte O.El Kasmy, El Kasmy Y.Martin-Borregon, P.Revilla, Ossola M.Van Straten, S.Aktas, M. K.Baki, B. E.Akhbari, M.Baker, D.Bhatia, S.Brown, S.Cambridge, W.Kamarajah, S. K.Khaw, R. A.Kouli, O.Murray, VTrout, IYasin, IWong, J.Reyhani, H.Wong, K. H. F.Pancharatnam, R.Chia, W. L.Walmsley, A.Hassane, A.Saeed, D.Wang, B.Walters, B.Nowinka, Z.Alsaif, A.Mirza, M.Foster, K.Luu, J.Kakodkar, P.Hughes, J. T.Yogarajah, T.Antypas, A.Rahman, A.Bradbury, M.McLarnon, M.Nagi, S.Riad, A. M.Erotocritou, M.Kyriacou, H.Kaminskaite, VAlfadhel, S.Hussain, Fatimah Q.Handa, A.Massy-Westropp, C.Custovic, S.Dimov, R.Mughal, H.Slavchev, M.Ivanov, T.Gouvas, N.Hegazi, A.Kocian, P.Kjaer, M. D.Mark-Christensen, A.Papakonstantinou, D.Machairas, N.Triantafyllou, T.Garoufalia, Z.Korkolis, D.Castaldi, A.Giaccari, S.Spolverato, G.Pagano, G.Milone, M.Turri, G.Colombo, F.Cucinotta, E.Poillucci, G.Perra, T.Tutino, R.Belia, F.Coletta, D.Belli, A.Rega, D.Cianci, P.Pirozzolo, G.Di Lena, M.Perrone, F.Giani, A.Lovisetto, F.Grassia, M.Federico, Pipitone N. S.Ferrara, F.Biancafarina, A.Tamini, N.Sinibaldi, G.Tuminello, F.Galleano, R.Sasia, D.Bragaglia, L.Garberini, de Manzoni A.Pesce, A.Cassaro, F.Venturelli, P.Canu, G. L.Esposito, G.Campanelli, M.Cardia, R.Ricciardiello, M.Sagnotta, A.Canonico, G.De Marco, G.Cappiello, A.Pinotti, E.Carlei, F.Lisi, G.Bagaglini, G.Farrugia, M.Meima-van Praag, E. M.Monteiro, C.Pereira, M.Botelho, P.Quigley, A.O'Neill, A.Gaule, L.Crone, L.Arnold, A.Grama, F.Beuca, A.Tulina, ILitvin, A.Panyko, A.Ossola, M. E.Diaz, Trujillo J.Santos, Marin J. M.Batanero, Alonso E.de las Casas, Gortazar S.Verdeguer, Soldevila C.Colas-Ruiz, E.El-Abur, Talal, IDominguez, Garcia M.Delorme, M.Sauvain, M.Ozmen, B. B.Ozkan, B. B.Calikoglu, F.Kural, S.Zafer, F.Kaya, Y.Yalcinkaya, A.Kargici, K.Tepe, M. D.Tatar, O. C.Kabadayi, E.Yildirim, A.Hurmuzlu, D.Korkmaz, K.Sharma, P.Troller, R.Hagan, N.Mooney, J.Light, A.Tansey, M.Bhojwani, D.McGing, R. M.Mallon, A.Fadel, M.Spilsbury, C.James, R.O'Brien, S.Isaac, A.Balasubramanya, S.Sadik, H.Gala, T.Chen, J. Y.Turner, B.Goh, E.Hassan, K.Karam, M.Mason, P.Tzoumas, N.Noton, T.Seehra, J. K.Ahmed, N.Motiwale, R.Tanna, VArgyriou, A.Bylapudi, S. K.Grace, N.Latif, S.Hounat, A.Kiam, J. S.Zaidi, M.Elsamani, K.Hughes, C.Suresh, A.Sinan, L. O. H.El-Dalil, D.Khoo, E. J. M.Salim, E. E.Stark, D.Minhas, N.Fowler, G.Rees, E.Giudiceandrea, IBardon, A.Jayawardena, P.Dieseru, N.Murphy, A.Yates, C.Ziolkowska, K.Rafie, A.Khoda, F.Okocha, M.Ashdown, T.Vitish-Sharma, P.Gilliland, J.Toh, S.Jones, K.Devine, A.Berry, A.McDonnell, S.Olivier, J.Richardson, G.Lim, H. J.Slim, N.Elsayeh, K.Sammour, T.Sarpanov, A.Belev, N.Dimitrov, D.Dusek, T.Ntomi, VSotiropoulos, G. C.Theodorou, D.Nikiteas, N.Balalis, D.Antropoli, C.Altomare, D. F.Luglio, G.De Palma, G. D.Pedrazzani, C.Simonelli, L.Brozzetti, S.Porcu, A.Massani, M.Grazi, G. L.Izzo, F.Delrio, P.Restini, E.Chetta, G.Lantone, G.Ferrari, G.Lucchi, A.De Prizio, M.Caristo, G.Borghi, F.Petrucciani, N.Huscher, C.Cocorullo, G.Tonini, VMedas, F.Sica, G.Cillara, N.Anastasi, A.Bianco, F.Giuliani, A.Carlini, M.Selvaggi, F.Sammarco, G.Ozolins, A.Malasonoks, A.Andrejevic, P.Tanis, P.van de Ven, A.Gerhards, M.da Silva, Ribeiro B.Silva, A.Lima, M. J.Kavanagh, D.McCawley, N.Bintintan, VKaramarkovic, A.Ortega, Sanz G.De Andres-Asenjo, B.Garcia, Nevado C.Florez, Garcia L. J.Segura-Sampedro, J. J.Laina, Blas J. L.Ponchietti, L.Buchwald, P.Gialamas, E.Ozben, VRencuzogullari, A.Gecim, I. E.Altinel, Y.Isik, O.Yoldas, T.Isik, A.Leventoglu, S.Erturk, M. S.Guner, A.Guler, S. A.Attaallah, W.Ugur, M.Ozbalci, G. S.Marzook, H.Eardley, N.Smolarek, S.Morgan, R.Roxburgh, C.Lala, A. K.Salama, Y.Singh, B.Khanna, A.Evans, M.Shaikh, IThippeswamy, Maradi K.Appleton, B.Moug, S.Smith, ISmart, N.Shah, P.Williams, G.Khera, G.Goede, A.Varcada, M.Parmar, C.Duff, S.Hargest, R.Marriott, P.Speake, D.Ben Sassi, A.Furfaro, B.Daudu, D.Golijanin, N.Yek, W. Y.Capasso, G.Mansour, L. T.Niu, N.Seow, W.Hamidovic, A.Kulovic, E.Letic, E.Aljic, A.Helez, M.Banji-Kelan, A.Dimitrova, N.Kavradjieva, P.Ivanov, VJukaku, A.Hadzhiev, D.Gabarski, A.Karamanliev, M.Vladova, P.Iliev, S.Yotsov, T.Vetsa, K.Stavrinidou, O.Papatheodorou, P.Liassides, T.Georgiou, T.Al Nassrallah, M.Altaf, R.Negametzyanov, M.Zagibova, D.Foltys, F.Stefanova, H.Paspala, A.Bompetsi, G.Sidiropoulos, T.Stamopoulos, P.Triantafyllou, A.Theodoropoulos, C.Kimpizi, A.Palyvou, T.Charalabopoulos, A.Syllaios, A.Schizas, D.Liatsou, E.Baili, E.Vagios, ITomara, N.Davakis, S.Palumbo, A.Foroni, F.Dibra, R.Papagni, VUrbani, A.Rossin, E.Nezi, G.Romano, P.Amendola, A.Esposito, E.Manigrasso, M.Anoldo, P.Vertaldi, S.Gecchele, G.Sabrina, Z. S.Guerci, C.Cammarata, F.Lamperti, G. M. B.Zaffaroni, G.Benuzzi, L.Ferrario, L.Cigognini, M.Mazzeo, C.Badessi, G.Pintabona, G.Fassari, A.Mingoli, A.Cirillo, B.D'Alterio, C.Brachini, G.Tancredi, M.Zambon, M.Aulicino, M.Sapienza, P.Liberatore, P.Scanu, A. M.Feo, C. F.Iacomino, A.Pelizzo, P.Rossi, S.Vigna, S. A.Grossi, U.Grillo, VAgnes, A.Schena, C. A.Marincola, G.Oddi, A.Perotti, B.Mario, VPerri, P.Zazza, S.Aversano, A.Scala, D.Di Lauro, K.Leongito, M.Piccirillo, M.Patrone, R.Capuzzolo, S.Vignotto, C.Bao, Q. R.Giuseppe, C.Angarano, E.Marino, F.Pezzolla, F.Gigante, G.Magistro, C.Crippa, J.Maspero, M.Carnevali, P.Trapani, R.Zonta, S.Agostinelli, L.Vittori, L.Romeo, L.Doria, E.Farnesi, F.Danna, R.Andolfi, E.Pellicano', G. A.Angelini, M.Scricciolo, M.Zanframundo, C.Ciulli, C.Ripamonti, L.Cigagna, L.Oldani, M.Larcinese, A.Rossi, D.Picone, E.Crescentini, G.Marano, A.Migliore, M.Giuffrida, M. C.Palagi, S.Testa, VBorrello, A.Lucarini, A.Garofalo, E.Canali, G.Orlandi, P.Nervegna, F.Marchegiani, F.Damoli, ILicata, A.Trovato, C.Alicata, F.Sardo, F.Milazzo, M.Randisi, B.Dominici, D. M.Sartarelli, L.Zanni, M.Pisanu, A.Soddu, C.Delogu, D.Erdas, E.Campus, F.Cappellacci, F.Casti, F.Marcialis, J.Atzeni, J.Podda, M. G.Sensi, B.Franceschilli, M.Bellato, VCannavera, A.Putzu, G.di Mola, F. F.Picardi, B.Solinas, L.Loponte, M.del Monte, Rossi S.Di Martino, C.Linari, C.Spagni, G.Capezzuoli, L.Tirloni, L.Nelli, T.Caridi, A.Elter, C.Camassa, M.D'Amico, S.Bargellini, T.Incollingo, P.Montuori, M.Maffione, F.Romano, L.Valiyeva, S.Spoletini, D.Tasselli, Menegon F.Sciaudone, G.Selvaggi, L.Menna, M. P.De Paola, G.Fulginiti, S.Truskovs, A.Weiss, C.Saknitis, G.Rauscher, J. T. R.Larnovskis, J.Jeyarajan-Davidsson, M.Nitisa, D.Gille, N.Reiser, S. C.Roshan, M. H. K.Leseman, C.Chen, J.van Dalen, A. S.Top, C.Detering, R.Matos, C.Silva, C.Pinto, D.Mendes, J.Couto, J.Leite, M.Velez, C.Cotovio, Damasio M.Cinza, A. M.de Lima, Pedroso R.Boyle, E.Yang, H. W.Banerjee, IRahmat, S.Afzal, Z.Reid, C.Dumitrascu, F.Croyle, J. A.Gressmann, K.Cullen, N.Graham, A.Nasehi, A.King, Montano C.Martin, B.Stokell, C.Sanderson, N.Farnan, R.Jassim, S.Chan, B.Long, Chua Vi K.Kaka, N.Pandey, S.Neo, W. X.Chitul, A.Bezede, C.Cincilei, D.David, A.Blaga, M.Blaga, S. N.Fagarasan, VKhetagurova, M.Rodimov, S.Kapustina, A.Mekhralyzade, A.Zabiyaka, M.Jankovic, U.Cuk, VHajska, M.Dubovsky, M.Hrosova, M.Ferancikova, N.Rodriguez, Camarero E.Alcantara, Laguna F.Adarraga, J.Jezieniecki, C.Soriano, Ruiz M.Sanz, Gomez T.Suarez, A.Garcia, Sanchez C.Canales, Cifrian, IPerez, Llosa J.Merayo, M.Urbieta, A.Simon, Gegundez A.Tone, J. F.Martinez, Gazo J.Bravo, Vicario M.Chavarrias, N.Catalan, Gil A.Oseira, A.Villalonga, B.Jeri, S.Calvo, Perez J.Nogues, A.Cros, B.Yanez, C.Fornals, Utrilla A.Golet, Roldon M.Colsa, P.Maurel, Gimenez T.Axmarker, T.Chevallay, M.Pham, T., VSel, E. K.Atar, C.Aba, M.Sarkin, M.Akkaya, Y. M.Durmaz, A. G.Gullu, H. F.Boga, A.Aktas, A.Bakar, B.Demirel, M. T.Hysejni, X.Taser, M.Guzel, O. R.Bozbiyik, O.Ozen, D.Olmez, M.Uyar, B.Gulcek, E.Kayacan, G. S.Atici, N.Gul, O. F.Altiner, S.Ibis, B.Altunsu, S.Banaz, T.Diler, C.Demirbas, IUsta, M. A.Erkul, O.Orman, R.Salih, S.Utkan, N. Z.Acil, C.Ozgur, E.Maddahali, M.Turhan, A. B.Eskici, A. B.Ular, B.Dogru, M.Ozturk, O. U.Arslan, E. R.Sharif, Panahi A.Dikmen, E.Ates, J.Bircan, R.Cavus, T.Sever, A. E.Balak, B.Duman, E.Altay, L.Emanet, O.Cullen, F.Tan, J. Y.Nathan, A.Rottenberg, A.Williams, C. Y.Mitrofan, C. G.Xu, D.Bawa, J. H.Morris, P.Gordon, D.Richmond, G.Hui, J. C.Ighomereho, O.Rocks, R.McCabe, S.Fitzpatrick, A.Nicoletti, J.Auterson, L.Darrah, N.Soh, V. W. Y.Ong, C. S.Utukuri, M.Gallagher, C.Stuart, L. M.Hipolito, M.Douglas, N.Ghazal, R.Parris, G.Catchpole, J.Bryden, M.Jamal, S.Karim, Z.Lyon-Dean, C.Rowley, G.Lee, K. S.Whitehurst, O.Mirza, A.Sheikh, F.Yousaf, H.Bilbao, J.Sinclair, R.Takar, S.Kressel, H.Chan, VSchack, K.Osborne, R.Baldemor, S.Smyth, S.Gilmour, S.Ting, A.Bozonelou, ISaunders, P.Anwar, Qhaireel Q. A.Tirimanna, R.Jauhari, S.Gardener, A.Walker, B.Wenban, C.Reddy, H.Conway-Jones, R.Loganathan, S.Clynch, A.James, C.Matey, E.Cameron, F.Roberts, W.Gicquel, A.Milliken, C.Forbes, J.Rubinchik, P.Azmi, A.Hawkes, C.Cornett, L.Adarkwah, P.McConville, R.O'Hara, S.Tijare, C.Parkes, J.Yao, L.Ahmad, R.Shafiq, U.Mhaisalkar, A.Gurung, A.de Stadler, K.Elias, S.Thomas, T.Madras, A.Jani, A.Daler, H. K.Tong, K. S.Sundaralingam, S. S.Szal, A.Khan, A.O'Sullivan, C.Baker, E.Joseph-Gubral, J.Hadley, E.Trivedi, R.Igwelaezoh, E.Barton, H.Allison, W.Hurst, W.Alam, F.Parkes, IJamshaid, M.Azizan, N.Burgher, T.Afzal, A.Eltilib, IZahid, M.Sadiq, O.Lloyd, A.Ho, R.Brazukas, A.Li, C. H.Kamdar, M.Nazeer, Mohamed M. N.Mighiu, A.Kim, D.Wilkins, L.Kuo, L.Rafe, T.Maduka, D.Cheema, H.Farag, K.Abdellatif, M.Nzewi, R.Kruczynska, A.Grasselli, H.Yousuff, M.Bassi, R.Mann, A. K.Chopra, J.Shaikh, M.Sa, D. S.Tsimplis, VGhanchi, A.Skene, E.Asim, K.Zaheer, M.Chan, S.Dalton, H.Gibbons, K.Adderley, O.Chukwujindu, IJayasuriya, ISivanu, K.Borumand, M.Chick, G.Bridges, ITomlin, J.McKenna, J.Nandra, N.Grieco, C.Quek, F. F.Mercer, R.Brankin-Frisby, T.Sattar, A.Aslam, A.Edelsten, E.Shafi, S.Kouli, T.Ford, VGurung, F.Fernandes, M.Deader, N.Ponniah, R.Jamieson, S.Davies, A.Taubwurcel, J.Aung, M. T.Desai, R.Begum, S.Jamadar, T.Kangatharan, A.Rzeszowski, B.Ho, C.Yap, S. H. K.Prendergast, M.Sethi, R.Duku, A.Lowe, C.Bray, J.Ghobrial, M.Nichita, VWagstaff, A.Rengasamy, E.Abu Hassan, F.Mahmood, H.Savill, N.Shah, S.Almeida, T.Edwards, A.Catchpole, B.Halford, Z.Carmichael, A.Alsusa, H.Boyd, M.Williams, J.Feyi-Waboso, J.Patel, M.Zeidan, Z.Bailey, E.Bapty, J.Brazkiewicz, M.Tremlett, A.Pringle, H.Mankal, S.Chung, W.Parry-Jones, E.Anderson, K.Mcforrester, A.Stanley, A.Hoather, A.Wise, H.Laid, IScriven, J.Braniste, A.Wilson, A.Le Blevec, L.Pakunwanich, N.Evans, N.Chong, H. L.White, C.Hunter, J.Haque, M.Vanalia, P.Murdoch, S.Choudhary, T.McCann, A.Harun, A.Shah, H.Hunt, S.Shafiq, Y.Bickley-Morris, E.Emms, L.Dare, M.Akula, Y.Deliyannis, E.Mayes, F.Ellacott, M.Zagorac, Z.Farren, A.Manning, C.Hughed, C.Stewart, E. G.Lim, K. H.Chohan, N.Thaker, A.Thompson, B.Ahari, D.Burdekin, E.Okwu, U.Akintunde, A.Lhaf, F.Douthwaite, J.Govindan, R.Leelamanthep, S.Gull, E.Wright, F.Dundas, L.Mackdermott, N.Burchi-Khairy, T.Campbell, IWalsh, J.Yeo, J. Y.Meehan, S.Banerjee, D.Fu, M.Kawka, M.Ali, T.Hussain, Z.Thomas, C.Ahmad, H.Moroney, J.Yick, C.Risquet, R.Ntuiabane, D.Shimato, M.Khan, M.Ilangovan, S.Vaselli, N. M.Smithers, R.Marage, Uhanowita R.Valnarov-Boulter, A.Kayran, J.Banerjee, M.Parekh-Hill, N.Hooper, A.Bowen, J.Jagdish, R.Mcquoid, C.Khan, N.Hare, O. R.Jeffery, S.Zahid, A.Elsworth, C.Walter, L.Dhillon, S.Rao, S.Anthony, A.Ashaye, A.Phillips, N.Faderani, R.Pengelly, S.Choi, S.Kwak, S. Y.Lau, Y. H. L.Bagheri, K.Ong, D. Y. C.Kerr, E.Falconer, K.Clancy, N.Douglas, S.Zhang, Y.Greenfield, F.Mutanga, IMcAlinden, J.Willis, L.Adefolaju, A.Agarwal, H.Barter, R.Harris, G.Spencer, G.Lee, M. W.Vadiveloo, T.Herbert, G.Patel, R.Shah, M.El Falaha, S.Wong, C.Soare, C.Akram, J.Bozhkova, L.Ma, Y.Vo, U. G.Tan, H. W. N.Leto, L.Kamal, M. A.Hadzhieva, E.Krastev, P.Tonchev, P.Kokkinos, G.Pozotou, ISabbagh, D.Votava, J.St, F.Koliakos, N.Tsaparas, P.Zografos, G.Mantas, D.Tsourouflis, G.Fradelos, E.Trigiante, G.Labellarte, G.Resta, G.Capelli, G.D'Amore, A.Verlingieri, V.Campagnaro, T.Maffioli, A.Viscosi, F.De Lucia, C.Meneghini, S.Fancellu, A.Colella, M.Biondi, A.De Peppo, VPace, U.Albino, VGattulli, D.Piangerelli, A.Kalivaci, D.Sisto, G.Mazzola, M.Caneparo, A.Lunghi, E. G.Nespoli, L. C.Angrisani, M.Langone, A.Gelarda, E.Virgilio, E.Angelini, E.Fornasier, C.Asero, S.Filippone, E.Frongia, F.Calo, P. G.Panaccio, P.Ipponi, P.Gili, S.Braccio, B.Tiesi, VStolcers, K.Kokaine, L.Novikovs, VCapel, L.Bastiaenen, VHeijmans, H.Henriques, S.Gan, S. Z.Ramanayake, H.Nolan, M.Temperley, H.Ciofic, E.Pop, B. A.Kurtenkov, M.Jovanovic, M.Vician, M.Arias, Egea P.de Heredia, Beltran J.Martinez, Labalde M.Alvarez, De Santiago, IAlvarez-Gallego, M.Artigas, Rodriguez J. M.Dwidar, O.Korkmaz, H. K.Eray, I. C.Meric, S.Aydin, R.Cetin, B.Karaca, B. E.Kuyumcu, O. F.Yuksel, E.Uprak, T. K.Karabulut, K.Kavukcu, E.Mansor, A.Hackett, R.Zammit-Maempel, M.Sabaratnam, R.Maan, A.Ferarrio, IDixon, L.Halai, H.Sethi, S.Nelson, L.Grassam-rowe, A.Krishnan, E.Deeny, D.McKeever, M.Pandeth, George A.Dhavala, P.Sreenivasan, S.Venkatesan, Sundaram G.Zhu, L.Atiyah, Z.Gregory, J.Morey, T.Seymour, Z.Holdsworth, L.Abdelmahmoud, S.Bourhill, J.Bisheet, G.Shaw, J.Kulkarni, K.Kumarakulasingam, P.Pillay, S.Al-Habsi, R.Kungwengwe, G.Richards, J.Davoudi, K.Ibrahim, B.Tailor, B.Zayed, M.Chen, F.Bailey, S.Sheefat, S.Nawaz, G.Pawar, R.Marsh, S.Sam, Z. H.Bentley, Roy S.Simpson, C.Hughes, J.Lim, Y.Ooi, R.Toh, W. H.Mannion, P.Lovett, A.Kincius, A.Hussein, S.Kirby, E.Beckett, R. G.Salmon, J.Glynn, T.Choo, S. Y.Lyons, S.Browne, D.Ravindran, W.Ahmad, S.Zhu, X.McNulty, J.McCarthy, L.Ng, J.Karmally, Z.McTeir, K.Hanna, M.Tan, E.Namdeo, S.Schembri, R.Pusey, E.EuroSurg Collaborative
COLORECTAL DISEASE; SEP 12 2023, 11p.
Academic Journal
Boos, J.Zametica, B.Heggemann, J.Schmidt, A.Ludwig, K.U.van der Made, C.I.Hoischen, A.Ramakrishnan, G.Coughlan, E.Pairo-Castineira, E.Baillie, J.K.Rawlik, K.Asselta, R.Löscher, B.-S.May, S.Franke, A.Ellinghaus, D.Valenti, L.V.C.Prati, D.Ronzoni, L.de Cid, R.Barretina, J.Blay, N.Bujanda, L.Banales, J.M.Albillos, A.Buti, M.Julià, A.Marsal, S.Bonfanti, P.Fernandez, J.Sacchi, N.Schultze, J.L.Riess, O.Rimoldi, V.Paraboschi, E.M.Bandera, A.Peyvandi, F.Grasselli, G.Blasi, F.Malvestiti, F.Pelusi, S.Bianco, C.Miano, L.Lombardi, A.Invernizzi, P.Gerussi, A.Citerio, G.Biondi, A.Valsecchi, M.G.Cazzaniga, M.E.Foti, G.Beretta, I.D'Angiò, M.Bettini, L.R.Farré, X.Iraola-Guzmán, S.Kogevinas, M.Castaño-Vinyals, G.Garcia-Etxebarria, K.Nafria, B.D'Amato, M.Palom, A.Begg, C.Clohisey, S.Hinds, C.Horby, P.Knight, J.Ling, L.Maslove, D.McAuley, D.Millar, J.Montgomery, H.Nichol, A.Openshaw, P.J.M.Pereira, A.C.Ponting, C.P.Rowan, K.Semple, M.G.Shankar-Hari, M.Summers, C.Walsh, T.Aravindan, L.Armstrong, R.Biggs, H.Boz, C.Brown, A.Clark, R.Coutts, A.Coyle, J.Cullum, L.Das, S.Day, N.Donnelly, L.Duncan, E.Fawkes, A.Fineran, P.Fourman, M.H.Furlong, A.Furniss, J.Gallagher, B.Gilchrist, T.Golightly, A.Griffiths, F.Hafezi, K.Hamilton, D.Hendry, R.Law, A.Law, D.Law, R.Law, S.Lidstone-Scott, R.Macgillivray, L.Maclean, A.Mal, H.McCafferty, S.Mcmaster, E.Meikle, J.Moore, S.C.Morrice, K.Murphy, L.Murphy, S.Hellen, M.Oosthuyzen, W.Zheng, C.Chen, J.Parkinson, N.Paterson, T.Schon, K.Stenhouse, A.Das, M.Swets, M.Szoor-McElhinney, H.Taneski, F.Turtle, L.Wackett, T.Ward, M.Weaver, J.Wrobel, N.Zechner, M.Arbane, G.Bociek, A.Campos, S.Grau, N.Jones, T.O.Lim, R.Marotti, M.Ostermann, M.Whitton, C.Alldis, Z.Astin-Chamberlain, R.Bibi, F.Biddle, J.Blow, S.Bolton, M.Borra, C.Bowles, R.Burton, M.Choudhury, Y.Collier, D.Cox, A.Easthope, A.Ebano, P.Fotiadis, S.Gurasashvili, J.Halls, R.Hartridge, P.Kallon, D.Kassam, J.Lancoma-Malcolm, I.Matharu, M.May, P.Mitchelmore, O.Newman, T.Patel, M.Pheby, J.Pinzuti, I.Prime, Z.Prysyazhna, O.Shiel, J.Taylor, M.Tierney, C.Wood, S.Zak, A.Zongo, O.Bonner, S.Hugill, K.Jones, J.Liggett, S.Headlam, E.Bandla, N.Gellamucho, M.Davies, M.Thompson, C.Abdelrazik, M.Bakthavatsalam, D.Elhassan, M.Ganesan, A.Haldeos, A.Moreno-Cuesta, J.Purohit, D.Vincent, R.Xavier, K.Rohit, K.Alasdair, F.Saleem, M.David, C.Samuel, J.Lamond, Z.Alanna, W.Fernandez-Roman, J.Hamilton, D.O.Johnson, E.Johnston, B.Martinez, M.L.Mulla, S.Shaw, D.Waite, A.A.C.Waugh, V.Welters, I.D.Williams, K.Cavazza, A.Cockrell, M.Corcoran, E.Depante, M.Finney, C.Jerome, E.McPhail, M.Nayak, M.Noble, H.O'Reilly, K.Pappa, E.Saha, R.Saha, S.Smith, J.Knighton, A.Antcliffe, D.Banach, D.Brett, S.Coghlan, P.Fernandez, Z.Gordon, A.Rojo, R.Arias, S.S.Templeton, M.Meredith, M.Morris, L.Ryan, L.Clark, A.Sampson, J.Peters, C.Dent, M.Langley, M.Ashraf, S.Wei, S.Andrew, A.Bashyal, A.Davidson, N.Hutton, P.McKechnie, S.Wilson, J.Baptista, D.Crowe, R.Fernandes, R.Herdman-Grant, R.Joseph, A.O'Connor, D.Allen, M.Loveridge, A.McKenley, I.Morino, E.Naranjo, A.Simms, R.Sollesta, K.Swain, A.Venkatesh, H.Khera, J.Fox, J.Andrew, G.Barclay, L.Callaghan, M.Campbell, R.Clark, S.Hope, D.Marshall, L.McCulloch, C.Briton, K.Singleton, J.Birch, S.Brimfield, L.Daly, Z.Pogson, D.Rose, S.Battle, C.Brinkworth, E.Harford, R.Murphy, C.Newey, L.Rees, T.Williams, M.Arnold, S.Polgarova, P.Stroud, K.Meaney, E.Jones, M.Ng, A.Agrawal, S.Pathan, N.White, D.Daubney, E.Elston, K.Grauslyte, L.Hussain, M.Phull, M.Pogreban, T.Rosaroso, L.Salciute, E.Franke, G.Wong, J.George, A.Ortiz-Ruiz de Gordoa, L.Peasgood, E.Phillips, C.Bates, M.Dasgin, J.Gill, J.Nilsson, A.Scriven, J.Delgado, C.C.Dawson, D.Ding, L.Durrant, G.Ezeobu, O.Farnell-Ward, S.Harrison, A.Kanu, R.Leaver, S.Maccacari, E.Manna, S.Saluzzio, R.P.Queiroz, J.Samakomva, T.Sicat, C.Texeira, J.Da Gloria, E.F.Lisboa, A.Rawlins, J.Mathew, J.Kinch, A.Hurt, W.J.Shah, N.Clark, V.Thanasi, M.Yun, N.Patel, K.Bennett, S.Goodwin, E.Jackson, M.Kent, A.Tibke, C.Woodyatt, W.Zaki, A.Abraheem, A.Bamford, P.Cawley, K.Dunmore, C.Faulkner, M.Girach, R.Jeffrey, H.Jones, R.London, E.Nagra, I.Nasir, F.Sainsbury, H.Smedley, C.Patel, T.Smith, M.Chukkambotla, S.Kazi, A.Hartley, J.Dykes, J.Hijazi, M.Keith, S.Khan, M.Ryan-Smith, J.Springle, P.Thomas, J.Truman, N.Saad, S.Coleman, D.Fine, C.Matt, R.Gay, B.Dalziel, J.Ali, S.Goodchild, D.Harling, R.Bhatterjee, R.Goddard, W.Davison, C.Duberly, S.Hargreaves, J.Bolton, R.Davey, M.Golden, D.Seaman, R.Cherian, S.Cutler, S.Heron, A.E.Roynon-Reed, A.Szakmany, T.Williams, G.Richards, O.Cheema, Y.Brooke, H.Buckley, S.Suarez, J.C.Charlesworth, R.Hansson, K.Norris, J.Poole, A.Rose, A.Sandhu, R.Sloan, B.Smithson, E.Thirumaran, M.Wagstaff, V.Metcalfe, A.Brunton, M.Caterson, J.Coles, H.Frise, M.Rai, S.G.Jacques, N.Keating, L.Tilney, E.Bartley, S.Bhuie, P.Gibson, S.Lyle, A.McNeela, F.Radhakrishnan, J.Hughes, A.Yates, B.Reynolds, J.Campbell, H.Thompsom, M.Dodds, S.Duffy, S.Greer, S.Shuker, K.Tridente, A.Khade, R.Sundar, A.Tsinaslanidis, G.Birkinshaw, I.Carter, J.Howard, K.Ingham, J.Joy, R.Pearson, H.Roche, S.Scott, Z.Bancroft, H.Bellamy, M.Carmody, M.Daglish, J.Moore, F.Rhodes, J.Sangombe, M.Kadiri, S.Croft, M.White, I.Frost, V.Aquino, M.Jha, R.Krishnamurthy, V.Lim, L.Lim, L.Combes, E.Joefield, T.Monnery, S.Beech, V.Trotman, S.Almaden-Boyle, C.Austin, P.Cabrelli, L.Cole, S.Casey, M.Chapman, S.Whyte, C.Baird, Y.Butler, A.Chadbourn, I.Folkes, L.Fox, H.Gardner, A.Gomez, R.Hobden, G.Hodgson, L.King, K.Margarson, M.Martindale, T.Meadows, E.Raynard, D.Thirlwall, Y.Helm, D.Margalef, J.Criste, K.Cusack, R.Golder, K.Golding, H.Jones, O.Leggett, S.Male, M.Marani, M.Prager, K.Williams, T.Roberts, B.Salmon, K.Anderson, P.Archer, K.Austin, K.Davis, C.Durie, A.Kelsall, O.Thrush, J.Vigurs, C.Wild, L.Wood, H.-L.Tranter, H.Harrison, A.Cowley, N.McAlindon, M.Burtenshaw, A.Digby, S.Low, E.Morgan, A.Cother, N.Rankin, T.Clayton, S.McCurdy, A.Ahmed, C.Baines, B.Clamp, S.Colley, J.Haq, R.Hayes, A.Hulme, J.Hussain, S.Joseph, S.Kumar, R.Maqsood, Z.Purewal, M.Benham, L.Bradshaw, Z.Brown, J.Caswell, M.Cupitt, J.Melling, S.Preston, S.Slawson, N.Stoddard, E.Warden, S.Deacon, B.Lynch, C.Pothecary, C.Roche, L.Howe, G.S.Singh, J.Turner, K.Ellis, H.Stroud, N.Hunt, J.Dearden, J.Dobson, E.Drummond, A.Mulcahy, M.Munt, S.O'Connor, G.Philbin, J.Rishton, C.Tully, R.Winnard, S.Cathcart, S.Duffy, K.Puxty, A.Puxty, K.Turner, L.Ireland, J.Semple, G.Long, K.Whiteley, S.Wilby, E.Ogg, B.Cowton, A.Kay, A.Kent, M.Potts, K.Wilkinson, A.Campbell, S.Brown, E.Melville, J.Naisbitt, J.Joseph, R.Lazo, M.Walton, O.Neal, A.Alexander, P.Allen, S.Bradley-Potts, J.Brantwood, C.Egan, J.Felton, T.Padden, G.Ward, L.Moss, S.Glasgow, S.Abel, L.Brett, M.Digby, B.Gemmell, L.Hornsby, J.MacGoey, P.O'Neil, P.Price, R.Rodden, N.Rooney, K.Sundaram, R.Thomson, N.Hopkins, B.Thrasyvoulou, L.Willis, H.Clark, M.Coulding, M.Jude, E.McCormick, J.Mercer, O.Potla, D.Rehman, H.Savill, H.Turner, V.Downes, C.Holding, K.Riches, K.Hilton, M.Hayman, M.Subramanian, D.Daniel, P.Adanini, O.Bhatia, N.Msiska, M.Collins, R.Clement, I.Patel, B.Gulati, A.Hays, C.Webster, K.Hudson, A.Webster, A.Stephenson, E.McCormack, L.Slater, V.Nixon, R.Hanson, H.Fearby, M.Kelly, S.Bridgett, V.Robinson, P.Camsooksai, J.Humphrey, C.Jenkins, S.Reschreiter, H.Wadams, B.Death, Y.Bastion, V.Clarke, D.David, B.Kent, H.Lorusso, R.Lubimbi, G.Murdoch, S.Penacerrada, M.Thomas, A.Valentine, J.Vochin, A.Wulandari, R.Djeugam, B.Bell, G.English, K.Katary, A.Wilcox, L.Bruce, M.Connolly, K.Duncan, T.T-Michael, H.Lindergard, G.Hey, S.Fox, C.Alfonso, J.Durrans, L.J.Guerin, J.Blackledge, B.Harris, J.Hruska, M.Eltayeb, A.Lamb, T.Hodgkiss, T.Cooper, L.Rothwell, J.Allan, A.Anderson, F.Kaye, C.Liew, J.Medhora, J.Scott, T.Trumper, E.Botello, A.Lankester, L.Nikitas, N.Wells, C.Stowe, B.Spencer, K.Brandwood, C.Smith, L.Birchall, K.Kolakaluri, L.Baines, D.Sukumaran, A.Apetri, E.Basikolo, C.Catlow, L.Charles, B.Dark, P.Doonan, R.Harvey, A.Horner, D.Knowles, K.Lee, S.Lomas, D.Lyons, C.Marsden, T.McLaughlan, D.McMorrow, L.Pendlebury, J.Perez, J.Poulaka, M.Proudfoot, N.Slaughter, M.Slevin, K.Thomas, V.Walker, D.Michael, A.Collis, M.Cosier, T.Millen, G.Richardson, N.Schumacher, N.Weston, H.Rand, J.Baxter, N.Henderson, S.Kennedy-Hay, S.McParland, C.Rooney, L.Sim, M.McCreath, G.Akeroyd, L.Bano, S.Bromley, M.Gurr, L.Lawton, T.Morgan, J.Sellick, K.Warren, D.Wilkinson, B.McGowan, J.Ledgard, C.Stacey, A.Pye, K.Bellwood, R.Bentley, M.Bewley, J.Garland, Z.Grimmer, L.Gumbrill, B.Johnson, R.Sweet, K.Webster, D.Efford, G.Convery, K.Fottrell-Gould, D.Hudig, L.Keshet-Price, J.Randell, G.Stammers, K.Bokhari, M.Linnett, V.Lucas, R.McCormick, W.Ritzema, J.Sanderson, A.Wild, H.Rostron, A.Roy, A.Woods, L.Cornell, S.Wakinshaw, F.Rogerson, K.Jarmain, J.Parker, R.Reddy, A.Turner-Bone, I.Wilding, L.Harding, P.Abernathy, C.Foster, L.Gratrix, A.Martinson, V.Parkinson, P.Stones, E.Carbral-Ortega, L.Bercades, G.Brealey, D.Hass, I.MacCallum, N.Martir, G.Raith, E.Reyes, A.Smyth, D.Zitter, L.Benyon, S.Marriott, S.Park, L.Keenan, S.Gordon, E.Quinn, H.Baines, K.Cagova, L.Fofano, A.Garner, L.Holcombe, H.Mepham, S.Mitchell, A.M.Mwaura, L.Praman, K.Vuylsteke, A.Zamikula, J.Purewal, B.Rivers, V.Bell, S.Blakemore, H.Borislavova, B.Faulkner, B.Gendall, E.Goff, E.Hayes, K.Thomas, M.Worner, R.Smith, K.Stephens, D.Mew, L.Mwaura, E.Stewart, R.Williams, F.Wren, L.Sutherland, S.-B.Bevan, E.Martin, J.Trodd, D.Watson, G.Brown, C.W.Collins, A.Khaliq, W.Gude, E.T.Akinkugbe, O.Bamford, A.Beech, E.Belfield, H.Bell, M.Davies, C.Jones, G.A.L.McHugh, T.Meghari, H.O'Neill, L.Peters, M.J.Ray, S.Tomas, A.L.Burn, I.Hambrook, G.Manso, K.Penn, R.Shanmugasundaram, P.Tebbutt, J.Thornton, D.Cole, J.Davies, R.Duffin, D.Hill, H.Player, B.Thomas, E.Williams, A.Griffin, D.Muchenje, N.Mupudzi, M.Partridge, R.Conyngham, J.-A.Thomas, R.Wright, M.Corral, M.A.Jacob, R.Jones, C.Denmade, C.Beavis, S.Dale, K.Gascoyne, R.Hawes, J.Pritchard, K.Stevenson, L.Whileman, A.Doble, P.Hutter, J.Pawley, C.Shovelton, C.Vaida, M.Butcher, D.O'Sullivan, S.Butterworth-Cowin, N.Ahmad, N.Barker, J.Bauchmuller, K.Bird, S.Cawthron, K.Harrington, K.Jackson, Y.Kibutu, F.Lenagh, B.Masuko, S.Mills, G.H.Raithatha, A.Wiles, M.Willson, J.Newell, H.Lye, A.Nwafor, L.Jarman, C.Rowland-Jones, S.Foote, D.Cole, J.Thompson, R.Watson, J.Hesseldon, L.Macharia, I.Chetam, L.Smith, J.Ford, A.Anderson, S.Birchall, K.Housley, K.Walker, S.Milner, L.Hanratty, H.Trower, H.Phillips, P.Oxspring, S.Donne, B.Jardine, C.Williams, D.Hay, A.Flanagan, R.Hughes, G.Latham, S.McKenna, E.Anderson, J.Hull, R.Rhead, K.Cruz, C.Pattison, N.Charnock, R.McFarland, D.Cosgrove, D.Ahmed, A.Morris, A.Jakkula, S.Ali, A.Brady, M.Dale, S.Dance, A.Gledhill, L.Greig, J.Hanson, K.Holdroyd, K.Home, M.Kelly, D.Kitson, R.Matapure, L.Melia, D.Mellor, S.Nortcliffe, T.Pinnell, J.Robinson, M.Shaw, L.Shaw, R.Thomis, L.Wilson, A.Wood, T.Bayo, L.-A.Merwaha, E.Ishaq, T.Hanley, S.Hibbert, M.Tetla, D.Woodford, C.Durga, L.Kennard-Holden, G.Branney, D.Frankham, J.Pitts, S.White, N.Laha, S.Verlander, M.Williams, A.Altabaibeh, A.Alvaro, A.Gilbert, K.Ma, L.Mostoles, L.Parmar, C.Simpson, K.Jetha, C.Booker, L.Pratley, A.Adams, C.Agasou, A.Arden, T.Bowes, A.Boyle, P.Beekes, M.Button, H.Capps, N.Carnahan, M.Carter, A.Childs, D.Donaldson, D.Hard, K.Hurford, F.Hussain, Y.Javaid, A.Jones, J.Jose, S.Leigh, M.Martin, T.Millward, H.Motherwell, N.Rikunenko, R.Stickley, J.Summers, J.Ting, L.Tivenan, H.Tonks, L.Wilcox, R.Holland, M.Keenan, N.Lyons, M.Wassall, H.Marsh, C.Mahenthran, M.Carter, E.Kong, T.Blackman, H.Creagh-Brown, B.Donlon, S.Michalak-Glinska, N.Mtuwa, S.Pristopan, V.Salberg, A.Smith, E.Stone, S.Piercy, C.Verula, J.Burda, D.Montaser, R.Harden, L.Mayangao, I.Marriott, C.Bradley, P.Harris, C.Anderson, S.Andrews, E.Birch, J.Collins, E.Hammerton, K.O'Leary, R.Clark, M.Purvis, S.Barber, R.Hewitt, C.Hilldrith, A.Jackson-Lawrence, K.Shepardson, S.Wills, M.Butler, S.Tavares, S.Cunningham, A.Hindale, J.Arif, S.Bean, S.Burt, K.Spivey, M.Demetriou, C.Eckbad, C.Hierons, S.Howie, L.Mitchard, S.Ramos, L.Serrano-Ruiz, A.White, K.Kelly, F.Cristiano, D.Dormand, N.Farzad, Z.Gummadi, M.Liyanage, K.Patel, B.Salmi, S.Sloane, G.Thwaites, V.Varghese, M.Zborowski, A.C.Allan, J.Geary, T.Houston, G.Meikle, A.O'Brien, P.Forsey, M.Kaliappan, A.Nicholson, A.Riches, J.Vertue, M.Allan, E.Darlington, K.Davies, F.Easton, J.Kumar, S.Lean, R.Menzies, D.Pugh, R.Qiu, X.Davies, L.Williams, H.Scanlon, J.Davies, G.Mackay, C.Lewis, J.Rees, S.Oblak, M.Popescu, M.Thankachen, M.Higham, A.Simpson, K.Craig, J.Baruah, R.Morris, S.Ferguson, S.Shepherd, A.Prockter Moore, L.S.Vizcaychipi, M.P.Gomes de Almeida Martins, L.Carungcong, J.Mohamed Ali, I.A.Beaumont, K.Blunt, M.Coton, Z.Curgenven, H.Elsaadany, M.Fernandes, K.Ally, S.M.Rangarajan, H.Sarathy, V.Selvanayagam, S.Vedage, D.White, M.Gill, M.Paul, P.Ratnam, V.Shelton, S.Wynter, I.Carmody, S.Page, V.J.Beith, C.M.Black, K.Clements, S.Morrison, A.Strachan, D.Taylor, M.Clarkson, M.D'Sylva, S.Norman, K.Auld, F.Donnachie, J.Edmond, I.Prentice, L.Runciman, N.Salutous, D.Symon, L.Todd, A.Turner, P.Short, A.Sweeney, L.Murdoch, E.Senaratne, D.Hill, M.Kannan, T.Laura, W.Crawley, R.Crew, A.Cunningham, M.Daniels, A.Harrison, L.Hope, S.Inweregbu, K.Jones, S.Lancaster, N.Matthews, J.Nicholson, A.Wray, G.Langton, H.Prout, R.Watters, M.Novis, C.Barron, A.Collins, C.Kaul, S.Passmore, H.Prendergast, C.Reed, A.Rogers, P.Shokkar, R.Woodruff, M.Middleton, H.Polgar, O.Nolan, C.Mahay, K.Collier, D.Hormis, A.Maynard, V.Graham, C.Walker, R.Knights, E.Price, A.Thomas, A.Thorpe, C.Behan, T.Burnett, C.Hatton, J.Heeney, E.Mitra, A.Newton, M.Pollard, R.Stead, R.Amin, V.Anastasescu, E.Anumakonda, V.Karthik, K.Kausar, R.Reid, K.Smith, J.Imeson-Wood, J.Skinner, D.Gaylard, J.Mullan, D.Newman, J.Brown, A.Crickmore, V.Debreceni, G.Wilkins, J.Nicol, L.Reece-Anthony, R.Birt, M.Ghosh, A.Williams, E.Allen, L.Beranova, E.Crisp, N.Deery, J.Hazelton, T.Knight, A.Price, C.Tilbey, S.Turki, S.Turney, S.Cooper, J.Finch, C.Liderth, S.Quinn, A.Waddington, N.Coventry, T.Fowler, S.MacMahon, M.McGregor, A.Cowley, A.Highgate, J.Gregory, J.O'Connell, S.Smith, T.Barberis, L.Gopal, S.Harris, N.Lake, V.Metherell, S.Radford, E.Daniel, A.Finn, J.Saha, R.White, N.Donnison, P.Trim, F.Eapen, B.Birch, J.Bough, L.Goodsell, J.Tutton, R.Williams, P.Williams, S.Winter-Goodwin, B.Nichol, A.Brickell, K.Smyth, M.Murphy, L.Coetzee, S.Gales, A.Otahal, I.Raj, M.Sell, C.Hilltout, P.Evitts, J.Tyler, A.Waldron, J.Beesley, K.Board, S.Kubisz-Pudelko, A.Lewis, A.Perry, J.Pippard, L.Wood, D.Buckley, C.Barry, P.Flint, N.Rekha, P.Hales, D.Bunni, L.Jennings, C.Latif, M.Marshall, R.Subramanian, G.McGuigan, P.J.Wasson, C.Finn, S.Green, J.Collins, E.King, B.Campbell, A.Smuts, S.Duffield, J.Smith, O.Mallon, L.Claire, W.Botfield, L.Butler, J.Dexter, C.Fletcher, J.Garg, A.Kuravi, A.Ranga, P.Virgilio, E.Belagodu, Z.Fuller, B.Gherman, A.Olufuwa, O.Paramsothy, R.Stuart, C.Oakley, N.Kamundi, C.Tyl, D.Collins, K.Silva, P.Taylor, J.King, L.Coates, C.Crowley, M.Wakefield, P.Beadle, J.Johnson, L.Sargeant, J.Anderson, M.Brady, A.Chan, R.Little, J.McIvor, S.Prady, H.Whittle, H.Mathew, B.Attwood, B.Parsons, P.Ward, G.Bremmer, P.Joe, W.Tracy, B.Jim, R.Davies, E.Sathe, S.Dennis, C.McGregor, A.Parris, V.Srikaran, S.Sukha, A.Clarke, N.Whiteside, J.Mascarenhas, M.Donaldson, A.Matheson, J.Barrett, F.O'Hara, M.Okeefe, L.Bradley, C.Eastgate-Jackson, C.Filipe, H.Martin, D.Maharajh, A.Garcia, S.M.Pakou, G.De Neef, M.Dent, K.Horsley, E.Akhtar, M.N.Pearson, S.Potoczna, D.Spencer, S.Clapham, M.Harper, R.Poultney, U.Rice, P.Mutch, R.Armstrong, L.Bates, H.Dooks, E.Farquhar, F.Hairsine, B.McParland, C.Packham, S.Bi, R.Scholefield, B.Ashton, L.George, L.Twiss, S.Wright, D.Chablani, M.Kirkby, A.Netherton, K.Davies, K.O'Brien, L.Omar, Z.Perkins, E.Lewis, T.Sutherland, I.Burns, K.Ben Chandler, D.Elliott, K.Mallinson, J.Turnbull, A.Gondo, P.Hadebe, B.Kayani, A.Masunda, B.Anderson, T.Hawcutt, D.O'Malley, L.Rad, L.Rogers, N.Saunderson, P.Allison, K.S.Afolabi, D.Whitbread, J.Jones, D.Dore, R.Halkes, M.Mercer, P.Thornton, L.Dawson, J.Garrioch, S.Tolson, M.Aldridge, J.Kapoor, R.Loader, D.Castle, K.Humphreys, S.Tampsett, R.Mackintosh, K.Ayers, A.Harrison, W.North, J.Allibone, S.Genetu, R.Kasipandian, V.Patel, A.Mac, A.Murphy, A.Mahjoob, P.Nazari, R.Worsley, L.Fagan, A.Bemand, T.Black, E.Dela Rosa, A.Howle, R.Jhanji, S.Baikady, R.R.Tatham, K.C.Thomas, B.Bell, D.Boyle, R.Douglas, K.Glass, L.Lee, E.Lennon, L.Rattray, A.Taylor, A.Hughes, R.A.Thomas, H.Rees, A.Duskova, M.Phipps, J.Brooks, S.Edwards, M.Quaid, S.Watson, E.Brayne, A.Fisher, E.Hunt, J.Jackson, P.Kaye, D.Love, N.Parkin, J.Tuckey, V.Van Koutrik, L.Carter, S.Andrew, B.Findlay, L.Adams, K.Service, J.Williams, A.Cheyne, C.Saunderson, A.Moultrie, S.Odam, M.Hall, K.Mapfunde, I.Willis, C.Lyon, A.Sri-Chandana, C.Scherewode, J.Stephenson, L.Marsh, S.Hardy, J.Houlden, H.Moncur, E.Tariq, A.Tucci, A.Hobrok, M.Loosley, R.McGuinness, H.Tench, H.Wolf-Roberts, R.Irvine, V.Shelley, B.Gorman, C.Gupta, A.Timlick, E.Brady, R.Milligan, B.Bellini, A.Bryant, J.Mayer, A.Pickard, A.Roe, N.Sowter, J.Howlett, A.Fidler, K.Tagliavini, E.Donnelly, K.
In: Human Genetics and Genomics Advances. (Human Genetics and Genomics Advances, 10 October 2024, 5(4))
검색 결과 제한하기
제한된 항목
[검색어] Wagstaff, V.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어